IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement

Abstract         The primary cause of branchio-oto-renal syndrome (BORS) is mutations in the EYA1 gene. The aim of this study was to investigate the clinical characteristics associated with induced podocyte reappearance in children with BORS and EYA1 mutations. We collected clinical and genetic data...

Full description

Saved in:
Bibliographic Details
Main Authors: Guanyu Li, Di Lu, Liujing Xu, Shumin Zhou, Jiayi Zhang, Lijuan Wu, Lingna Shi, Lili Wang, Xiaoqing Lin, Zhigang Ma, Ming Liu, Xia Gao
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Cellular and Molecular Life Sciences
Subjects:
Online Access:https://doi.org/10.1007/s00018-025-05724-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849237648137256960
author Guanyu Li
Di Lu
Liujing Xu
Shumin Zhou
Jiayi Zhang
Lijuan Wu
Lingna Shi
Lili Wang
Xiaoqing Lin
Zhigang Ma
Ming Liu
Xia Gao
author_facet Guanyu Li
Di Lu
Liujing Xu
Shumin Zhou
Jiayi Zhang
Lijuan Wu
Lingna Shi
Lili Wang
Xiaoqing Lin
Zhigang Ma
Ming Liu
Xia Gao
author_sort Guanyu Li
collection DOAJ
description Abstract         The primary cause of branchio-oto-renal syndrome (BORS) is mutations in the EYA1 gene. The aim of this study was to investigate the clinical characteristics associated with induced podocyte reappearance in children with BORS and EYA1 mutations. We collected clinical and genetic data from a 4-year-old girl diagnosed with BORS and her family. Induced pluripotent stem cells (iPSC) were derived from peripheral blood mononuclear cells of both the patient and healthy individuals, which were differentiated into podocytes in vitro. RNA-seq was used to analyze differentially expressed genes in both groups. Here, the proband, along with his brother and mother, exhibited symptoms of BORS. WES analysis identified a heterozygous splicing variant at the EYA1 locus: c.1050 + 5G > A, inherited from his mother. The proband was initially glucocorticoid-resistant. After tacrolimus treatment, his urine protein/creatinine ratio significantly improved. Compared to healthy individuals, patient-derived podocytes displayed increased motility and pronounced cytoskeletal rearrangement. RNA-Seq results indicated significant downregulation of cell adhesion molecule and cytoskeletal rearrangement signaling pathway expression in patient-derived podocytes. Dexamethasone was ineffective in ameliorating the pathological damage induced by puromycin aminonucleoside in patient-derived podocytes. In BORS patients, podocytes exhibit cytoskeletal reorganization and enhanced motility in vitro while showing resistance to steroid treatment. These findings were consistent with the clinical features observed in the patient, suggesting that this unique cellular disease model merits further investigation.
format Article
id doaj-art-e58e8f4573fe41bf928e7434030531c6
institution Kabale University
issn 1420-9071
language English
publishDate 2025-06-01
publisher Springer
record_format Article
series Cellular and Molecular Life Sciences
spelling doaj-art-e58e8f4573fe41bf928e7434030531c62025-08-20T04:01:53ZengSpringerCellular and Molecular Life Sciences1420-90712025-06-0182111610.1007/s00018-025-05724-7IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangementGuanyu Li0Di Lu1Liujing Xu2Shumin Zhou3Jiayi Zhang4Lijuan Wu5Lingna Shi6Lili Wang7Xiaoqing Lin8Zhigang Ma9Ming Liu10Xia Gao11Nephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityPediatrics, Gansu Provincial HospitalDepartment of Radiology, Gansu Provincial HospitalNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Longgang District People’s Hospital of ShenzhenGuangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityNephrology Department, Guangzhou Women and Children’s Medical Center, Guangzhou Medical UniversityAbstract         The primary cause of branchio-oto-renal syndrome (BORS) is mutations in the EYA1 gene. The aim of this study was to investigate the clinical characteristics associated with induced podocyte reappearance in children with BORS and EYA1 mutations. We collected clinical and genetic data from a 4-year-old girl diagnosed with BORS and her family. Induced pluripotent stem cells (iPSC) were derived from peripheral blood mononuclear cells of both the patient and healthy individuals, which were differentiated into podocytes in vitro. RNA-seq was used to analyze differentially expressed genes in both groups. Here, the proband, along with his brother and mother, exhibited symptoms of BORS. WES analysis identified a heterozygous splicing variant at the EYA1 locus: c.1050 + 5G > A, inherited from his mother. The proband was initially glucocorticoid-resistant. After tacrolimus treatment, his urine protein/creatinine ratio significantly improved. Compared to healthy individuals, patient-derived podocytes displayed increased motility and pronounced cytoskeletal rearrangement. RNA-Seq results indicated significant downregulation of cell adhesion molecule and cytoskeletal rearrangement signaling pathway expression in patient-derived podocytes. Dexamethasone was ineffective in ameliorating the pathological damage induced by puromycin aminonucleoside in patient-derived podocytes. In BORS patients, podocytes exhibit cytoskeletal reorganization and enhanced motility in vitro while showing resistance to steroid treatment. These findings were consistent with the clinical features observed in the patient, suggesting that this unique cellular disease model merits further investigation.https://doi.org/10.1007/s00018-025-05724-7Branchio-oto-renal syndromeInduced pluripotent stem cellsPodocytes
spellingShingle Guanyu Li
Di Lu
Liujing Xu
Shumin Zhou
Jiayi Zhang
Lijuan Wu
Lingna Shi
Lili Wang
Xiaoqing Lin
Zhigang Ma
Ming Liu
Xia Gao
IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
Cellular and Molecular Life Sciences
Branchio-oto-renal syndrome
Induced pluripotent stem cells
Podocytes
title IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
title_full IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
title_fullStr IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
title_full_unstemmed IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
title_short IPSC-induced podocytes from a BORS patient with EYA1 gene mutation showed glucocorticoid-resistant and cytoskeletal rearrangement
title_sort ipsc induced podocytes from a bors patient with eya1 gene mutation showed glucocorticoid resistant and cytoskeletal rearrangement
topic Branchio-oto-renal syndrome
Induced pluripotent stem cells
Podocytes
url https://doi.org/10.1007/s00018-025-05724-7
work_keys_str_mv AT guanyuli ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT dilu ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT liujingxu ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT shuminzhou ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT jiayizhang ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT lijuanwu ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT lingnashi ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT liliwang ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT xiaoqinglin ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT zhigangma ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT mingliu ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement
AT xiagao ipscinducedpodocytesfromaborspatientwitheya1genemutationshowedglucocorticoidresistantandcytoskeletalrearrangement